Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tilray

Nike, Tilray, and Palantir: Their Unusually Active Put Options Will Boost Your Wallet After Christmas

Christmas has gotten more expensive this year due to inflation and tariffs. Americans of all stripes can use a break. These six unusually active put options from Thursday trading could boost your wallet the day after Christmas. Ho. Ho. Ho!

Barchart

Option Traders Are Pricing a Nearly 22% Move in Tilray Stock Before the End of 2025. Should You Buy, Sell, or Hold TLRY Here?

Tilray stock soared today after President Donald Trump signalled reclassification of cannabis as a Schedule III drug in the near-term. Here’s what that means for TLRY shares heading into 2026.

Barchart

As Trump Considers Signing a Cannabis Executive Order, Should You Buy the Dip in Tilray Stock?

Down almost 98% from all-time highs, Tilray is a Canada-based cannabis stock that surged over 40% on Friday.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Why Tilray Stock Is Sliding Again Wednesday

Tilray Brands Inc (NASDAQ:TLRY) shares are trading lower Wednesday morning, extending a 24% drop over the trailing five sessions following the execution of a corporate restructuring. Here’s what investors need to know.

Benzinga

Robinhood, Beyond Meat, Tilray Brands, ASML And SMX (Security Matters): Why These 5 Stocks Are On Investors' Radars Today

Stocks surged ahead of the Thanksgiving holiday, with the tech-heavy Nasdaq leading the charge, gaining 0.82% to 23,214.69. The SP 500 gained 0.69% to 6,812.61, while the Dow Jones Industrial Average gained 0.67% to 47,427.12.Investors are optimistic as the market enters a typically strong period for corporate sales. Fresh labor-market…

Benzinga

Tilray Shares Tumble After Company Announces 1-For-10 Reverse Stock Split

Tilray Brands Inc (NASDAQ:TLRY) shares are trading lower in Wednesday’s after-hours session after the company announced a reverse stock split.

Benzinga

Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use

Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher on Wednesday after a Marijuana Moment report cited findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions. Here’s what investors need to know.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Riding the Green Wave: Exposure to the CBD market

As the cannabidiol (CBD) market continues its upward growth trajectory, investors are looking for exposure to this substance.

inkl

What's Going On With Tilray Brands Stock Today?

Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading lower on Tuesday.

Benzinga

Should You Buy, Sell, or Hold Tilray Stock After Q1 Earnings?

Tilray’s strong Q1 sent cannabis stocks flying, but sustaining this high means proving profits, not just promises.

Barchart

Tilray Stock Is Sliding Friday: What's Going On?

Tilray Brands Inc (NASDAQ:TLRY) shares are trading lower Friday morning, a sharp reversal after the stock hit a new 52-week high on Thursday. Here’s what investors need to know.

Benzinga

Tilray (TLRY) Stock Surges To New 52-Week High On Strong Q1 Earnings Report

Tilray Brands Inc (NASDAQ:TLRY) shares are trading higher Thursday afternoon following the release of a strong first-quarter fiscal 2026 earnings report. Here’s what investors need to know.

Benzinga

Tilray Delivers Q1 Earnings Surprise, Strengthens Balance Sheet With Lower Debt

Tilray Brands Inc. (NASDAQ:TLRY) stock is surging on Thursday after the cannabis company reported better-than-expected first-quarter 2026 earnings.

Benzinga

As Tilray Expands Its Medical Cannabis Business, Should You Buy, Sell, or Hold TLRY Stock?

Tilray’s rapid expansion in Germany and the launch of five new EU-GMP-certified craft products put it at the forefront of Europe’s largest medical cannabis market, but current analyst targets remain below the stock’s price.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Is Tilray's Stock Price Surge a Pipe Dream of Political Hype?

Tilray's stock surge, fueled by political commentary and a technical squeeze, is now focusing market attention on its strong financial health.

Benzinga

What's Going On With Tilray Brands Stock Tuesday?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading lower Tuesday morning, giving back a portion of the previous session’s explosive gains. The stock is experiencing a correction after surging over 35% on Monday, a rally ignited by a weekend social media post from President Donald Trump.

Benzinga

Tilray Stock Is Trading Higher Monday: What's Going On?

Tilray Brands, Inc. (NASDAQ: TLRY) shares are trading higher Monday after President Donald Trump shared a video that discussed potential medical benefits of CBD for seniors.

The Guardian - US

Cannabis stocks soar after Trump shares video promoting drug’s use for seniors

Video posted on Truth Social touts CBD as a ‘gamechanger’ and promotes Medicaid coverage of CBD products

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Are Cannabis Stocks Ready for a Long-Term Rebound?

Cannabis stocks are soaring today in light of some positive remarks from President Donald Trump. What implications could this have for the industry’s long-term prospects?

Benzinga

What's Going On With Tilray Stock Today?

Tilray Brands, Inc. (NASDAQ:TLRY) shares gained ground on Thursday after the marijuana company’s medical division expanded its portfolio in Germany with three newly certified cannabis strains.

Barchart

Tilray’s Stock Price Is Growing Like a Weed. Here’s Why, and What Comes Next.

With rescheduling on the table, here are two option trades to play the potential spike in TLRY stock.

Benzinga

What's Going On With Tilray Brands (TLRY) Stock?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading higher Tuesday, with the stock up 39% over the past week. Here’s what investors need to know.

Benzinga

Tilray Stock Continues To Rally After Hours: Here's Why Its Moving

Pharmaceuticals and cannabis lifestyle company, Tilray Brands Inc. (NASDAQ:TLRY), rallied 20.87% on Monday and is now showing no signs of slowing down, with another 4.32% gain after hours, as broad-based tailwinds begin to align in the company’s favor.

Barchart

Jefferies Just Raised Its Tilray Stock Price Target 33%. Should You Buy TLRY Here?

Tilray stock extends gains as Jefferies raises its price target on the cannabis firm to $2. But caution is warranted as TLRY shares are already up some 300% versus their year-to-date low.

Benzinga

Tilray Brands (TLRY) Stock Is Surging Monday: What's Going On?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading sharply higher Monday morning, bolstered by a positive note from Jefferies and growing optimism around significant U.S. cannabis reform this year. Jefferies analyst Kaumil Gajrawala maintained a Buy rating on the stock while raising the price target from $1.50 to $2.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Palantir Technologies

Robinhood Markets, Inc.

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.